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Laval, Que´bec, QC, CanadaAbstract—We have witnessed an accelerated growth of pho-
tonics technologies in recent years to enable not only mon-
itoring the activity of speciﬁc neurons, while animals are
performing certain types of behavior, but also testing
whether speciﬁc cells, circuits, and regions are suﬃcient
or necessary for initiating, maintaining, or altering this or
that behavior. Compared to other sensory systems, how-
ever, such as the visual or olfactory system, photonics
applications in pain research are only beginning to emerge.
One reason pain studies have lagged behind is that many of
the techniques originally developed cannot be directly
implemented to study key relay sites within pain pathways,
such as the skin, dorsal root ganglia, spinal cord, and brain-
stem. This is due, in part, to diﬃculties in accessing these
structures with light. Here we review a number of recent
advances in design and delivery of light-sensitive molecular
probes (sensors and actuators) into pain relay circuits to
help decipher their structural and functional organization.
We then discuss several challenges that have hampered
hardware access to speciﬁc structures including light scat-
tering, tissue movement and geometries. We review a num-
ber of strategies to circumvent these challenges, by
delivering light into, and collecting it from the diﬀerent key
sites to unravel how nociceptive signals are encoded at
each level of the neuraxis. We conclude with an outlookhttp://dx.doi.org/10.1016/j.neuroscience.2016.09.035
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248on novel imaging modalities for label-free chemical detec-
tion and opportunities for multimodal interrogation in vivo.
While many challenges remain, these advances oﬀer
unprecedented opportunities to bridge cellular approaches
with context-relevant behavioral testing, an essential step
toward improving translation of basic research ﬁndings into
clinical applications.
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INTRODUCTION
Why light? The future of pain research lies in developing
the ability to assess, in a context-sensitive manner, how
each component of the enormously complex CNS
integrates, processes and transfers information. Thisons.org/licenses/by-nc-nd/4.0/).
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study the organization of brain microcircuits and the
dynamic mechanisms that govern their function across a
broad range of scales: from synapses -and even
nanoscale substructures within synapses- to entire
microcircuits in the intact brain during behavior. Light-
based tools represent the disruptive, enabling
technology in this endeavor. Light has just the right
energy (i) to non-destructively probe or control biological
molecules (proteins, ion channels, receptors, lipids),
enabling non-invasive studies and interventions, and (ii)
to image ultra-rapidly at spatial resolutions down to the
nanoscale. Thus, by exploiting light with proper tools,
one can gain access, at one end, to molecular signaling
events at single synapses, and at the other end, to
whole animal physiology and behavior, providing the
opportunity to bridge the diﬀerent levels of complexity of
brain functions.
A number of revolutions that occurred over the last
decades now converge to make the use of light the tool
of choice to enable cracking the neural code and the
pain code. First, the introduction of ﬂuorescence
microscopy transformed life sciences by making
molecular imaging possible in live cells and tissues at
unmatched spatial resolution and speed. But it is the
many ﬂavors of nonlinear optical interactions, enabled
by the advent of robust ultrafast pulsed lasers, that
turned this transformation into a revolution. Their highly
conﬁned interaction volumes limit the photodamage,
increase the spatial resolution, and oﬀer optimal light
collection strategies for imaging in deep tissue (Denk
et al., 1990; Stosiek et al., 2003; Zipfel et al., 2003;
Helmchen and Denk, 2005; Lutcke and Helmchen,
2011). Then by exploiting clever beam shaping strategies,
or the properties of ﬂuorophores, it has been possible to
push spatial resolution beyond the diﬀraction limit (Hell
and Wichmann, 1994; Betzig et al., 2006; Rust et al.,
2006). Beyond ﬂuorescence, nonlinear interactions pro-
vide endogenous contrast mechanisms sensitive to
molecular symmetry and orientation (e.g., high harmonic
generation imaging) and biochemical species (e.g.,
Raman spectroscopy).
The advent of photoactivatable proteins to generate
novel sensors and actuators is another revolution that
has opened an immense array of possibilities to
dramatically enhance the throughput of microcircuit
dissection, enabling the monitoring and control of the
activity of hundreds to thousands of cells
simultaneously, with genetic speciﬁcity (Hamel et al.,
2015). The possibilities do not end there, as the growing
array of genetically-encoded tools expands, almost on a
weekly basis, to enable monitoring a multitude of cellular
events (not just ions, but also enzymatic reactions and
molecular arrangements) and to enable control of a simi-
lar multitude of events (triggering/stopping enzymatic
reactions, releasing and ablating molecular components).
And these occur in an ever growing palette of spectral
ranges, opening avenues for multiple simultaneous inter-
ventions across cells populations, and even within diﬀer-
ent cell compartments (Zhao et al., 2011b; Zou et al.,
2014; Shen et al., 2015). The paradigm shift here is that,for the ﬁrst time, speciﬁcity in sensing or stimulating in the
CNS is not only determined by spatial factors, (i.e., by the
precision of the light delivery or collection system) thus
allowing precise probing yet within highly entangled neu-
ral circuits. It is this asset that makes optogenetics partic-
ularly enabling: to conduct precise cellular and molecular
signaling manipulations in the intact brain of a behaving
animal, hence in relevant context.
Parallel developments in optical ﬁbers and micro-
optical components, to carry light without aberrations,
have enhanced the realm of possibilities for
miniaturization and local sensing deep in tissue in freely
behaving animals (Dufour and De Koninck, 2015). Never-
theless, challenges remain to harness the full potential of
optical approaches and optical probes due to diﬀraction,
absorption and scattering which restrict resolution and
depth of observation or intervention.
The purpose of this review is to provide an overview of
the diﬀerent optical approaches being developed that can
be exploited to probe neural mechanisms within the
diﬀerent components of pain pathways, from skin to
cortex. These approaches can be divided into two
general categories: visualizing (static structures,
dynamic molecular interactions and neuronal activity)
and manipulating (modifying or breaking molecular
conﬁguration). This involves tools at both ends: at the
receiving end, in the tissue, the wetware, i.e., molecular
components incorporated into cells to produce the
signal, and at the other end, the hardware, i.e., laser-
based microscopy and ﬁber-optics technologies to send
light to the appropriate place and collect it to interpret
the signal. Emphasis will be placed on promises
(opportunities) and limitations (challenges) each
approach presents. We will ﬁrst brieﬂy summarize the
chemical and genetically-encoded probes to monitor
(ﬂuorescent sensors) and control (actuators) neuronal
activity. We will focus on strategies and challenges to
deliver these probes within the proper compartments of
pain pathways (e.g., sensory aﬀerents, spinal cord). We
will then discuss the diﬀerent microscopy and ﬁber
optics-based technologies that can be used to make
maximal use of these probes to decode how signals are
encoded at each level of the neuraxis (at the molecular,
cellular, circuit and behavioral levels). We will ﬁnally
describe how light-based technologies can be exploited
to probe without extrinsic labels, which is critical for
clinical applications.SENSORS
A wide array of chemical probes has been developed over
the years to enable optical monitoring of neuronal activity
and cell signaling events with high spatial and temporal
resolution. These have been extensively discussed in
recent reviews (Knopfel et al., 2006; Grienberger and
Konnerth, 2012; Kilgore et al., 2014; Loew, 2015). Here
we focus speciﬁcally on the genetically-encoded sensors
(Ca2+, voltage, glutamate and intracellular signaling path-
ways) because they oﬀer the advantage of being targeted
to speciﬁc populations of cells, that represent compo-
nents of nociceptive pathways.
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Genetically encoded indicators of neural activity (GINAs)
have been developed to transduce Ca2+ or voltage
ﬂuctuations into changes in ﬂuorescence (Looger and
Griesbeck, 2012). GINAs are based on chimeric ﬂuores-
cent proteins (FPs), and as they are encoded by DNA,
they can be targeted to genetically-deﬁned cell popula-
tions. Combined with ﬂuorescence microscopy, GINAs
oﬀer the ability to monitor activity from a wide array of indi-
vidual cells within a circuit (e.g., sensory ganglion, spinal
cord, thalamus, cortex) (Greenberg et al., 2008; Kerr and
Denk, 2008; Kerr and Nimmerjahn, 2012), but also within
small cellular components that have remained particularly
diﬃcult to access with electrophysiological techniques
(e.g., sensory aﬀerent terminals in peripheral tissue or
axonal boutons), an application that remains to be devel-
oped and that will be particularly enabling to understand
signal transduction in sensory receptors and presynaptic
modulation. Genetically-encoded Ca2+ indicators
(GECIs) typically consist of a calcium-binding domain
(e.g., calmodulin or troponin C), fused to one or two FP
(Tian et al., 2012). In GECIs with single-FP, such as
GCaMPs and GECOs, the ﬂuorescence intensity of the
circularly permuted or split FP is controlled by Ca2+-
dependent changes in the chromophore environment
(Akerboom et al., 2009). In GECIs with two-FP, like
D3cpV, binding to Ca2+ allosterically changes the relative
emission spectra of the donor–acceptor pair through
change in Fo¨rster resonance energy transfer (FRET)
(Tian et al., 2012). Recent developments in protein engi-
neering have dramatically improved the performance of
GECIs, to the point of making them the sensors of choice
to monitor Ca2+ in live cells. Improvements include
widening the palette of excitation and emission spectra,
Ca2+ aﬃnity, kinetics, dynamic range, and subcellular tar-
geting of diﬀerent GECIs (Broussard et al., 2014; Rose
et al., 2014; Shen et al., 2015). While there is still room
for further improvements on some of the parameters, sen-
sor linearity, toxicity and resistance to lysosomal targeting
remain key challenges (Rose et al., 2014; Inoue et al.,
2015; Shen et al., 2015). The choice of optimal sensor
for an application often entails a compromise between dif-
ferent characteristics (e.g., sensitivity vs. kinetics) as for
any chemical-based Ca2+ sensor (Grienberger and
Konnerth, 2012). The fact that these Ca2+ sensors act
as buﬀers incorporates measurement biases and causes
them to interfere with function, which needs to be taken
into consideration when interpreting the data. Cellular traf-
ﬁcking issues remain a challenge particularly with the red-
shifted variants (Shen et al., 2015). The circularly per-
muted (GCaMPs and GECOs) have been more widely
used, yet FRET-based sensors oﬀer certain advantages
that can make them more suitable for certain applications.
For example, they can serve as ratiometric indicators,
which can be instrumental to measure steady state
Ca2+ levels and to avoid various background signals;
they may also oﬀer improved dynamic range and more lin-
ear response properties (Thestrup et al., 2014). The ﬁeld
of genetically-encoded voltage indicators (GEVIs) has
grown very rapidly in recent years, again bringing the
GEVI to a range where they are usable for many applica-tion. Several strategies have been used to engineer them.
The two predominant solutions have been FRET-based
sensors or more recently sensors based on microbial rho-
dopsins (Akemann et al., 2010; Broussard et al., 2014; St-
Pierre et al., 2015; Storace et al., 2015). While GEVIs
potentially oﬀer advantages over GECIs that they provide
a direct readout of voltage and thus are more proximal
indicators of electrical activity, their use still suﬀers from
limited sensitivity, insuﬃcient dynamic range, and slow
kinetic properties (Storace et al., 2015). It is important to
note this is a consequence of the limited number of pho-
tons produced during the short action potential compared
to the longer Ca2+ waves, which leads to a sizable noise
in the signal (shot noise). For this reason, GECIs have
remained the main tool used to report neuronal activity.
Yet, it should be noted that while GECIs are very often
used to monitor ﬁring activity of neurons, in many
instances, it is the Ca2+ ﬂuctuations themselves that
are the signal of interest (e.g., presynaptic release,
Ca2+ oscillations in neurons or glia). This is true for other
ions as well and the development of other ion sensors
(e.g., H+, Na+, Cl, K+, Mg2+, Zn2+) is an essential step
to be able to completely decipher information coding by
neurons and glia (Kuner and Augustine, 2000; Grimley
et al., 2013; Lindenburg et al., 2013; Doyon et al., 2016;
Hessels et al., 2016; Lee et al., 2016). Where GEVIs will
be particularly instrumental is to measure electrical
responses in cellular compartments that are not easily
accessible to electrophysiological techniques, such as
sensory receptors in peripheral tissue or axon terminals
(e.g., primary aﬀerent terminals in the spinal dorsal horn).
GEVIs may also be transformative in allowing to measure
membrane potential ﬂuctuations in spatially ramiﬁed com-
partments of cells (e.g., voltage propagation along den-
drites or at diﬀerent synapses within a dendrite or
across dendrites). However, the current signal-to-noise
(SNR) they yield remains insuﬃcient to allow robust mea-
surement of individual events (i.e., without signal averag-
ing and hence lower temporal resolution).
Genetically-encoded neurotransmitter sensors
Beyond monitoring neural activity, direct monitoring of
chemical signaling between cells is key to understand
signal processing. The most used neurotransmitter
sensors to date have been glutamate sensors, including
FLIPE (Okumoto et al., 2005), GluSnFR (Tsien, 2005),
super-GluSnFR (Hires et al., 2008), and iGluSnFR
(Marvin et al., 2013). They are based on the glutamate-
binding domain and a reporter element (a single FP or
two FPs). To date, iGluSnFR oﬀers the highest sensitivity,
photostability, and a superior SNR (Marvin et al., 2013).
On the other hand, FLIPE, GluSnFR and super-
GluSnFR are FRET-sensors, which may be useful to
measure steady state levels. The sensitivity of the probes
allow for measurement of release events at single-
synapse, and even clearance (Liang et al., 2015;
Parsons et al., 2016) but can also be used to monitor
propagation of activity at the network scale, using trans-
mitter release as a proxy (Xie et al., 2016). Another strat-
egy to generate neurotransmitter reporters has been to
use stable expression of a speciﬁc G protein-coupled
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ergic for norepinephrine) in HEK293 cells, which express
Gq/11 G proteins and a Ca2+ sensor. The cells can be
embedded into the tissue and ambient transmitters can
activate the receptor to trigger a Ca2+ signal in the repor-
ter cell (Nguyen et al., 2010; Muller et al., 2014). Other
transmitter sensors are emerging (ATP, GABA (Liang
et al., 2015)), but development of neuropeptide reporters
will be particularly instrumental to decode complex synap-
tic signaling at all levels in pain pathways.Sensors for intracellular signaling pathways
Perhaps even more transformative is the ability to monitor
intracellular signaling events in intact tissue. GFP-based
ﬂuorescent sensors have been developed for cAMP,
receptor tyrosine kinases, and other molecules
(Miyawaki, 2003; Souslova and Chudakov, 2007). Diﬀer-
ent strategies have been used; for instance, both GFP
tagged PKA (Zaccolo et al., 2000) and EPAC-based
FRET probes (Ponsioen et al., 2004) have been devel-
oped for cAMP detection. For receptor tyrosine kinases,
Raichu is a hybrid protein consisting of H-Ras and the
Ras binding domain of Raf, and it could be used to detect
the activation of Ras, as a readout of the activation of
receptor tyrosine kinases (Mochizuki et al., 2001). Perce-
valHR was developed as a genetically-encoded biosensor
of ATP-to-ADP ratio (Tantama and Yellen, 2014), based
on a protein sensor, GlnK, which binds both MgATP and
ADP (Berg et al., 2009), coupled to a reporter domain,
based on a circularly permuted version of Venus. It
senses the ATP/ADP ratio because the ﬂuorescence
spectrum resulting from MgATP binding is diﬀerent from
that of ADP binding. Also, intracellular level of PIP3 can
be monitored by PIP-SHOW, which will translocate from
the cytosol to the plasma membrane when the concentra-
tion of PIP3 increases. Thus, the membrane/cytosol ratio
of PIP-SHOW can serve as a readout of the PIP3 concen-
tration (Mishina et al., 2012).
Several of these sensors described above have pH
sensitivity (YFP and the circularly-permuted GFP used
in many of these sensors operate on the basis of H+
quenching) that needs to be taken into account, either
by running control experiments with pH-only sensors
(we used for example a variant of clomeleon that is Cl
insensitive but retains pH sensitivity; (St-Pierre et al.,
2015)) or by combining with pH sensors with spectral
properties (e.g., pHRed) that are compatible with those
of the sensor being used (Tantama and Yellen, 2014).ACTUATORS
Besides monitoring, manipulating activity of speciﬁc
neurons, precisely, within very short temporal windows,
is necessary to uncover the causal relationships
between certain elements of neural circuits and
behaviors. Optogenetics has been revolutionizing in this
context because of the ability to control deﬁned
subcomponents of neural circuits with speciﬁcity and
temporal precision comparable to that of the normal
electrical activity of neurons, and independent of spatialprecision (i.e., the light stimulus does not have to be
conﬁned to a speciﬁc cell or cell compartment) (Zhang
et al., 2010; Tye and Deisseroth, 2012; Grosenick et al.,
2015; Rajasethupathy et al., 2016). While many tools have
been developed, in recent years, the opsin-based tools
have dominated the scene, in part because they are
single-component actuators, greatly enhancing robust-
ness and ease of use (Deisseroth, 2015; Kandori, 2015;
McIsaac et al., 2015). The topics of opsins in neuroscience
has been the subject of numerous reviews (e.g., Zhang
et al., 2010, 2011; Adamantidis et al., 2014; Gautier
et al., 2014; Zhou et al., 2015). Similar to sensors, devel-
opment challenges include channel kinetics, conductance,
ion selectivity, spectral bandwidth and traﬃcking
(Gunaydin et al., 2010; Lin, 2011; Mattis et al., 2012;
Tye and Deisseroth, 2012; Klapoetke et al., 2014). These
properties have been important limitations for their use in
pain pathways. For example, the small single-channel
conductance of channelrhodopsin-2 (ChR2) means that
high level of the protein has to be expressed to produce
excitation. This has been a limiting factor for the control
of certain cell types or within certain cellular compart-
ments. For example, initial attempts at expressing ChR2
in sensory aﬀerents failed to yield an eﬀective tool for exci-
tation across the skin (Wang and Zylka, 2009) and only
strategies boosting expression levels such that suﬃcient
opsins were expressed at sensory receptor endings
yielded an eﬀective remote activation of aﬀerents (Daou
et al., 2013). As will be discussed below, remote control
across highly scattering tissue, such as skin and brain,
which minimizes excitation eﬃciency, has also been dra-
matically improved by using red-shifted opsins (Lin,
2011; Tye and Deisseroth, 2012; Lin et al., 2013;
Klapoetke et al., 2014; Rajasethupathy et al., 2015). The
expanding palette of spectrally-shifted opsins opens ave-
nues for selective activation (and inactivation) simultane-
ously, using diﬀerent wavelengths of light, but the
approach remains limited by overlap in excitation band-
widths; proper calibration and care are required to eﬀec-
tively separate them (Zhang et al., 2011; Chuong et al.,
2014; Klapoetke et al., 2014; Rajasethupathy et al.,
2015). Challenges with inhibitory opsins include the fact
that most of them have been based on ion pumps (Cl
for Halorhodopsin, NpHR; H+ for Archaerhodopsin, Arch
and ArchT) (Han and Boyden, 2007; Zhang et al., 2007;
Chow et al., 2010; Han et al., 2011), with potential side
eﬀects, such as collapse in Cl gradients (Gradinaru
et al., 2007; Raimondo et al., 2012) and pH changes
(Mahn et al., 2016). Rebound excitation, due to [Cl]i
accumulation following the end of NpHR activation, for
example, can confound interpretation of results
(Gradinaru et al., 2007; Raimondo et al., 2012). The recent
advent of Cl permeable opsins may prove instrumental
(Berndt et al., 2014; Govorunova et al., 2015; Wietek
et al., 2015), with the caveat that one still has to consider
diﬀerences in Cl homeostasis among cells types and that
the complex interplay between Cl and other ionic and cel-
lular processes can yield unintuitive results (Doyon et al.,
2011, 2016; Mahn et al., 2016). In fact, even so-called
shunting inhibition is aﬀected by labile Cl homeostasis
(Doyon et al., 2016).
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particular pain optogenetics, is the advent of light-
activated G protein-coupled receptors (OptoXR) (Airan
et al., 2009; Bruchas and Roth, 2016) or soluble (bacterial
cyclase) receptors (Stierl et al., 2011). For example, a
light-activated l-opioid receptor (Opto-MOR) was devel-
oped by fusing the intracellular component of Opto-
MOR with the photoisomerizing retinal binding site of
the rat rhodopsin RO4 (Airan et al., 2009; Siuda et al.,
2015). These open new avenues, ﬁrst to study the role
of these signaling mechanisms in speciﬁc functions, but
also because they couple to eﬀector mechanisms through
intracellular signaling pathways with the potential for
ampliﬁcation, yielding more eﬃcient excitation or inhibi-
tion than conventional opsins. OptoXR can be used to
drive the function of Gq, Gs, or Gi, respectively, for exam-
ple, oﬀering a wide array of options (Airan et al., 2009;
Bruchas and Roth, 2016). Yet, the possibilities opened
by optogenetics do not stop there, in particular with the
advent of photoactivatable enzymes. For example, pho-
toactivatable Cre recombinases (Schindler et al., 2015;
Taslimi et al., 2016) open avenues for spatially and tem-
porally selective activation of genes. Similarly, photo-
cleavable proteins open a wide array of opportunities for
enzyme uncaging (Rathert et al., 2007; Umeda et al.,
2011; Zhou et al., 2015). A new class of biosensors was
also developed based on the reversible exchange of the
heterodimeric partners of green and red proteins, whose
ﬂuorescence intensity is dimerization dependent (Ding
et al., 2015). This strategy was used to visualize caspase
activity upon binding and diﬀerential targeting of the sub-
strate fragments after cleavage (Ding et al., 2015).TARGETING
A key challenge, whether using chemical or genetically-
encoded reporter or actuators, is their introduction into
cells, and especially into the proper target cells. Here
we focus on approaches and challenges that are
particularly relevant to pain pathways, especially
sensory neurons and spinal pathways.Loading of chemical dyes
While genetically-encoded markers oﬀer many
advantages over conventional chemical labeling
approaches, the latter still have their niche and in many
instances remain the technique of choice (for reviews,
see Ribeiro-da-Silva and De Koninck, 2002; Marks and
Nolan, 2006; Lazarov, 2013). For morphometric analyses,
intracellular injection of dyes (Fig. 1B) remains the refer-
ence to ensure complete labeling of the ﬁnest dendritic pro-
ﬁles, for example, and non-ﬂuorescent labels can provide
more reliable quantiﬁcation than ﬂuorescent ones for anal-
ysis of small cellular compartments where rapid photo-
bleaching can become a liability (Wong et al., 2000;
Cordero-Erausquin et al., 2009; Allard et al., 2012). Photo-
conversion of ﬂuorescent dyes or their detection by anti-
bodies is an alternative oﬀering the advantage that the
cells can rapidly be identiﬁed after intracellular labeling, fol-
lowed by detailed morphometric analysis after conversionor immunodetection to yield electron-dense material, com-
patible with ultrastructural analysis (Buhl and Lubke, 1989;
Bories et al., 2013). Intracellular labeling remains the tech-
nique of choice for combined morphometric and functional
analysis (Prescott and De Koninck, 2002; Ribeiro-da-Silva
and De Koninck, 2002; Labrakakis et al., 2009), but juxta-
cellular labeling has been particularly instrumental for
in vivo studies (Pinault, 2011). For targeting speciﬁc cells
types, retrograde labeling with chemical dyes, or
chemically-tagged proteins (e.g., latex microspheres, DiI,
biotinylated dextran amines, ﬂuorescently-tagged beta
subunit of cholera toxin), remains a technique of choice
(Buhl and Lubke, 1989; Yu et al., 1999, 2005; Chery
et al., 2000; Kobbert et al., 2000; Vercelli et al., 2000)
Fig. 1B). Drawbacks of retrograde labeling techniques
include missed labeling when terminals are very sparsely
distributed in the target nucleus (false negative) or labeling
of en passant axons (false positives). Single, juxtacellular
cell labeling followed by anterograde tracing, while very
laborious, is one approach that has served to unequivo-
cally determine projection patterns (Wu et al., 2000;
Parent and Parent, 2006).
For functional imaging, chemical Ca2+ dyes have long
been the tool of choice. Beyond intracellular single-cell
labeling during electrophysiological recording, the most
popular loading technique has been using acetoxymethyl
ester (AM) forms of the dyes, which can be loaded into
neurons though bolus tissue injections (Coull et al.,
2003; Cordero-Erausquin et al., 2005). The approach
works in vivo as well (e.g., using local pressure ejection
after laminectomy) (Johannssen and Helmchen, 2010;
Laﬀray et al., 2011; Ran et al., 2016). The depth and range
of labeled cells are mainly determined by the depth of the
tip of the glass pipette, the amount and concentration of
dye used, and the speed of injection, which need to be
optimized empirically. Diﬀerential loading of neurons vs.
glia varies with dye, tissue and preparation (e.g., culture,
slices vs in vivo; Oregon Green BAPTA-AM appears to
load preferentially in neurons in vivo, but this is not neces-
sarily the case in other preparations). Combining bolus
loading of Ca2+ dyes with neuronal- or glial-speciﬁc mark-
ers is often used to separate the two populations
(Romanelli et al., 2013). While chemical voltage dyes have
not robustly translated into usable tools for single-cell
studies they have proven instrumental for mesoscopic
functional studies in the cortex (Lim et al., 2015). The
approach has been used to measure activity within cortical
surfaces located just below the cranium; in contrast, corti-
cal structures typically associated with pain (ACC and
Insula) are much deeper structures. Even more problem-
atic is the brainstem and spinal cord, which is covered with
a heavy layer of myelinated ﬁbers. It is therefore unlikely
that such an approach will be usable for activity mapping
at the mesoscale within pain pathways.
Transducing genetically-encoded sensors and
actuators – transgenic strategies
For in vivo studies, GINAs or opsins are typically targeted
using transgenic or viral-vector-mediated strategies.
Conventional knock-in or transgenic approaches (based
on BAC or simpler cDNA transgenes) have been used
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vectors selectively transduce primary sensory neurons (insets show labeling in DRG, but no labeling of dorsal horn neurons). Scale bars:
Top = 50 lm; Bottom = 100 lm. From Bonin et al. (2016). (B) Retrograde labeling can be combined with intracellular injection of dyes in ﬁxed or
live tissue for complete ﬁlling of cells for morphometric analysis. (C) Retrograde transduction can be achieved with a vector directly encoding a
ﬂuorescent protein (FP). Here a case for retrograde and trans-synaptic labeling is illustrated, either using a FP-chimera (e.g., GFP-TTC) or a trans-
synaptically transported viral vector (e.g., pseudorabies). (D). Retrograde transduction can be used an intersectional approach, combining
retrograde transport of a Cre expressing AD viral vector, injected in the thalamus, followed by local spinal injection of AAV vector encoding a Cre-
dependent FP.
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2011a). Overexpression of the transgene may be prob-
lematic in some cases (Kramer et al., 2011) and speci-
ﬁcity of the transgene expression needs to be
conﬁrmed. A more versatile approach is the use of well
characterized transgenic mice expressing Cre recombi-
nase under a speciﬁc promoter (Agarwal et al., 2004;
Stirling et al., 2005; credrivermice.org), coupled with
mouse lines encoding the protein of interest whose
expression is Cre-dependent. Limitations in using Cre-
dependent strategies include ‘‘leakiness”, but also devel-
opmental shifts in expression. The expression of many
genes are known to ﬂuctuate dramatically during the early
development or switch from one population of neurons to
another (Cavanaugh et al., 2011; Peirs et al., 2015). Tran-
sient expression of Cre can be suﬃcient to cause expres-
sion of the target transgene throughout the life, yielding
oﬀ-target expression of GINAs or opsins in undesired
cells. Strategies to circumvent this include the use of indu-
cible Cre recombinase systems (tamoxifen = CRE-ER ortetracyclin = Tet-ON-Oﬀ based). These approaches still
have drawbacks including smaller expression range of
the Cre-induced exogenous protein vs. that of Cre itself,
which is dependent on the dose of the chemical inducer
and, in the case of the Tet approach, a third genetically
encoded component (tetracyclin activator protein rtTA)
which adds to the complexity of the system (Jullien
et al., 2008; Wang, 2009). An emerging powerful alterna-
tive is the use of intersectional genetics (Prescott et al.,
2014). In the latter case, a combination of FLPo and
Cre recombinase expression driven by diﬀerent promot-
ers is used, combined with a target gene whose expres-
sion depends on both FLPo and Cre. Only cells
expressing both types of recombinase will express the
gene, conﬁning targeting more precisely. Yet a major lim-
itation of the use of recombinase-dependent transgenic
mice is the time it takes to generate them. Given the rate
at which optogenetic tools evolve, often several new iter-
ations of the constructs have evolved by the time the
mouse is generated.
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Largely due to the short experimental time associated
with their production, viral vectors have become a very
attractive alternative to the generation of genetically
modiﬁed mouse lines (Lentz et al., 2012; Kantor et al.,
2014; Murlidharan et al., 2014). They can be injected
postnatally on their own to express some of the tools
mentioned above (GINAs or others) or to deliver recombi-
nases such as Cre, which may help circumvent some of
the leakiness problems often encountered when Cre is
expressed during embryogenesis and early postnatal
stage. Viral vectors can be designed to use strong pro-
moters and yield signiﬁcant ampliﬁcation of expression,
which is often critical with the expression of opsins (see
above and Daou et al., 2013). The eﬃcacy of viral-
mediated gene transduction depends primarily on the
right combination of virus, titer, promoter, and delivery
method (Parr-Brownlie et al., 2015; Skipper and
Mikkelsen, 2015) (Table 1). Transduction of local subpop-
ulation of cells using intraparenchymal injections of
viruses encoding Cre-dependent vectors is achieved rou-
tinely nowadays and the vectors of choice are lentiviruses
and Adeno associated virus (AAV).
For transduction of spinal neurons, unfortunately,
intrathecal administration of viral vectors often fails to
infect dorsal horn neurons (likely because of the surface
white matter) (Towne et al., 2009; Kao et al., 2010;
Vulchanova et al., 2010) (however see Li et al., 2016).
As with brain regions, one has to revert to intra-spinal
injection of AAVs (or lentiviruses). Fortunately, this typi-
cally results in selective transduction of dorsal horn neu-
rons with no expression in sensory aﬀerents (DRG),
which is instrumental for selective targeting of CNS vs.
PNS (Tappe et al., 2006; Lu et al., 2015). A drawback
for intra-spinal injection is the invasive surgery of laminec-
tomy required for the injection, although, in mice, injection
can be performed between vertebrae without laminec-
tomy (Tappe et al., 2006; Lu et al., 2015). The surgery
nevertheless remains more invasive than for brain
injections.
Another strategy to target speciﬁc pathways without
using the Cre-Lox system is to use retrogradely
transported viral vectors that encode a protein of
interest (Fig. 1C). Speciﬁcity is associated with the
delivery route (projection pattern of the neurons). The
human (Ad5) and canine (CAV-2) adenoviruses have
been the dominant choice to date (Junyent and Kremer,
2015) despite the production of a local immune response
for the AD5 (Hendrickx et al., 2014). Several pseudotypes
of AAVs have also been reported to be transported retro-
gradely but less eﬃciently and with great variability
(Murlidharan et al., 2014 and Paquet, unpublished). More
recently, HIV based lentiviral vectors have been success-
fully pseudotyped with rabies virus glycoprotein (RV-G) to
allow for retrograde transport while keeping the ease of
production and other advantages of lentiviruses
(Mazarakis et al., 2001; Kato et al., 2011; Hirano et al.,
2013). One approach that is growing in popularity is the
combination of retrogradely transported viral vector
encoding Cre followed by local injection of an AAV encod-
ing a Cre-dependent transgene (Fig. 1D). Recent strate-gies such as FLEX cassettes (Atasoy et al., 2008),
which have been developed to obtain more dependable
Cre-dependent expression, have been instrumental in
achieving speciﬁcity in this system. The retrograde trans-
port of Cre oﬀers the advantage of ampliﬁcation as only
few copies of the Cre are needed to produce full blown
expression of the gene transduced by the local AAV vec-
tor. This combinatorial projection method also avoids local
expression of the target protein in the projection site as
well as expression in other pathways projecting to the site
where the retrogradely transported vector is injected. An
important consideration to keep in mind is that, in the
end, each viral vector tool yields variable results depend-
ing of the cell type and tissue approaches; they must
therefore be tested in each experimental paradigm.
A major advantage of expressing genetically-encoded
ﬂuorescent markers is the opportunity it oﬀers to conduct
very detailed morphometric analysis of the target cells
(Cordero-Erausquin et al., 2009). For this to be achieved,
complete ﬁlling of even the smallest cellular proﬁles is
important. One strategy developed to fully visualize den-
dritic processes for example, has been to attach a lipid
modiﬁcation to an FP. Myristoylation appears to result in
better targeting of GFP to the membrane than other mod-
iﬁcations such as palmitoylation or farnesylation. These
modiﬁcations sometimes induce aggregation in red FPs,
unfortunately, resulting in poor labeling (Kameda et al.,
2008). When trying to both visualize and control neurons
with the same molecular construct, a diﬀerent strategy
may be useful. Indeed, it appears that using bicistronic
expression of the opsin and the FP optimizes expression
and membrane localization of a functional opsin together
with high levels of cytoplasmic FP (Gradinaru et al.,
2010). Similarly, expression within axonal arborization,
down to the smallest branches can be critical for both
morphometric analysis (e.g., analysis of sprouting) but
also for optogenetic stimulation of aﬀerent terminals. To
engineer such an axonal-ﬁlling label, the insertion of a
transport signal at the end of an FP has proven success-
ful. For instance, the 30UTR of neuritin (NRN) RNA, which
is known to be involved in the transport of NRN to distal
axons (Merianda et al., 2013), has been shown to improve
tremendously the labeling of neural projections (Ye et al.,
2016). It should be kept in mind however that opsins-
based stimulation of synaptic terminals does not replicate
the normal activation mechanism (action potential inva-
sion). Depending on the objectives sought, more distal
activation of aﬀerents, away from the terminals, may be
a more appropriate stimulus to recapitulate the normal
physiological process.
While transduction of CNS neurons has been
relatively straightforward, targeting peripheral (sensory)
neurons has remained more challenging, in particular in
adult tissue, likely because of the connective tissue
surrounding nerve endings in the skin and cell bodies in
the DRG. Recently, it was found, however, that sensory
aﬀerents can be selectively transduced using certain
AAV serotypes when injected systemically in newborn
animals (Fig. 1A). Intraperitoneal injection (IP) injection
of AAV8 (Foust et al., 2008; Vrontou et al., 2013) or
AAV9 (Machida et al., 2013) on postnatal day 1 (P1) to
Table 1. Palette of viral vectors available for in vivo gene transduction
Virus type Foreign DNA
size
Transport and spread Transgene expression Characteristics BSL* References
Human Adenovirus
(AD5)
8 kb  Retrograde  Fast (days)
 Long lasting episomal
(most cell types)
 Infects replicating and non-replicating cells
 Risk of inﬂammation
 High titers
 Production time can be long (up to 2 months)
 Tropism toward respiratory and hepatic cells
2 Campos and Barry (2007)
Arnberg (2012)
Canine Adenovirus
(CAV2)
8 kb  Retrograde (faster than AD5)  Fast (days)
 Long lasting episomal
(most cell types)
 Infects replicating and non-replicating cells
 No inﬂammation
1 Lerner et al. (2015), Szelechowski
et al. (2013)
Junyent and Kremer (2015)
Adeno-Associated
Virus (ssAAV)
(scAAV)
4.8 kb (incl.
promoter)
scAAV:
2.4 kb (incl.
promoter)
 Paravascular CSF and axonal
transport depends on serotype,
route and species
 Slow (weeks-months)
 scAAV faster (days)
 Long lasting occasional
integration in host genome
 Infects replicating and non-replicating cells
 Certain level of tropism can be obtained with
the different serotypes
 No known disease association
 Natural immunity; minimal inﬂammation
1 Murlidharan et al. (2014)
scAAV: McCarty (2008)
Lentivirus 8 kb  Limited compared to AAV
 Retrograde if pseudotyped with
rabies virus glycoprotein (RV-G)
 Fast (days)
 Integration in host genome
 Risk of insertional mutagenesis
 Infects replicating and non-replicating cells
 Fast stable but variable expression.
Integrating
 Minimal immunity and inﬂammation to vector
itself
2 Parr-Brownlie et al. (2015)
Hirano et al. (2013)
Herpes simplex
virus HSV-1
150 kb  Retrograde; perhaps some antero-
grade, trans-synaptic
 Long lasting episomal
 Tend to be silenced by
innate anti-viral response
 Cytopathic effects in culture
 Inﬂammation in vivo
2 Epstein (2009)
Nassi et al. (2015)
Pseudorabies 140 kb  Neurotrophic but infect replicating
and non-replicating cells
 Retrograde and trans-synaptic
 Cytotoxic; longer expres-
sion (months) w/ gene-
deleted versions
2–3§ Pomeranz et al. (2005)
Nassi et al. (2015)
Rabies 3.7 kb (no
promoter)
 Trans-synaptic monosynapse only
if G-deleted & used with
transcomplementation
 Primarily retrograde; some antero-
grade (primary afferents)
 Fast (days)
 Short term (cell death)
 Neurotropic
 No risk of insertional mutagenesis
2 Osakada and Callaway (2013),
Wickersham et al. (2007)
Kim et al. (2016b), Tsiang et al.
(1989), Zampieri et al. (2014), Zhang
et al. (2015)
Retrovirus 8 kb  Local only  Fast (days)
 Integration in host genome
 Infects replicating cells only
 Risk of insertional mutagenesis
 Minimal immunity and inﬂammation to vector
itself
2
Simliki forest /
Sindbis
4 kb (no
promoter)
 Local only  Very fast (hours) & short
term (cell death)
 High levels of transgene
expression
 Neurotropic
 Cannot use cell speciﬁc promoter
2 Nassi et al. (2015)
Ehrengruber (2002)
* Biosafety level; can vary depending on regulatory agencies.
§ Not a human pathogen but level 2–3 for agriculture, country-dependent.
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all DRG neurons. The advantages of this delivery method
is that it is easy to perform and no surgery is required. A
disadvantage is that the expression can be leaky if a
recombinase system is used, since the injection is carried
out in newborn mice. Intra-sciatic nerve injection of AAV6
(with a synapsin promoter) in adult mice has been
reported to speciﬁcally transduce in nociceptors (Iyer
et al., 2014). The eﬃciency is lower compared to IP injec-
tion with only 16% of DRG neurons transduced. Speciﬁc
labeling of nociceptors may be an advantage if this is the
population of aﬀerents targeted. Primary aﬀerents can
also be targeted by direct injection of lentivirus
(Schweizerhof et al., 2009; Simonetti et al., 2014;
Selvaraj et al., 2015) or AAV (Simonetti et al., 2014; Li
et al., 2015; Vicuna et al., 2015) into the DRG. The
approach is very invasive however. It was also reported
that intrathecal (IT) delivery of double-stranded AAV2
(dsAAV2) (Kao et al., 2010), AAV5 (Vulchanova et al.,
2010), AAV8 (Vulchanova et al., 2010) and lentivirus (Li
et al., 2016) can transduce DRG neurons in both adult
mice and rats. Pre-treatment with intravenous mannitol
appears critical to increase the eﬃciency of the transduc-
tion (Vulchanova et al., 2010). Both AAV5 and AAV8 pref-
erentially transduce into large-diameter aﬀerents. Within
the small-diameter aﬀerent population both viruses
appear to transduce preferentially into the peptidergic
subpopulation. The cell type preference for dsAAV2 is
unknown (Kao et al., 2010). An advantage of intrathecal
injection is that it is easier to perform than intra-sciatic
injection, but the transduction rate is lower and it remains
to be determined how uniform the transduction is across
the DRG.
Trans-synaptic strategies
Several approaches have been used for trans-synaptic
labeling or transfer of genes across synapses. The
approach can be very powerful to target a population of
cells that is pre- or postsynaptic to a speciﬁc element of
the circuit. Retrograde trans-synaptic labeling has been
used to target neurons presynaptic to projection
neurons (Fig. 1C) and anterograde approaches can be
used through aﬀerent input to a speciﬁc nucleus.
Strategies include using retrogradely transported viral
vectors, either directly encoding a trans-synaptic protein
or protein chimera. For example, the nontoxic fragment
C of the tetanus toxin (TTC) can be retrogradely
transported through a synapse and a GFP-Cre-TTC
chimera can eﬀectively be used to transfer GFP across
synapses (Coen et al., 1997; Kissa et al., 2002). Early
strategies used rabies viruses for retrograde trans-
synaptic labeling. The approach is powerful for anatomi-
cal tracing, but not for functional approaches since the
virus is toxic, and they require a high level of biosafety
conﬁnement. Pseudorabies virus have been an interest-
ing alternative (Jasmin et al., 1997). Since the virus is
what is transported across the synapse, the system self-
perpetuates and eventually all cells are labeled. Carefully
timed interruptions of the transport is needed to interpret
monosynaptic jumps. The advantage of the GFP-Cre-
TTC approach is that it is the protein that is transportedhence typically yielding single synapse jump. This was
used successfully to identify neurons presynaptic to lam-
ina I projection neurons (Cordero-Erausquin et al., 2009).
Tracing of the neural circuitry has also been done with
EnvA-pseudotyped G deleted Rabies virus (RVdG). This
technology allows for retrograde transport and eﬃcient
trans-synaptic spread of the viral vector but works through
complementation and thus requires multiple components
such as a helper virus to deliver G in trans and a mouse
line expressing EnvA’s cognate receptor TVA (Sakurai
et al., 2013; Stanek et al., 2014; Kim et al., 2016b). For
anterograde trans-synaptic tracing, transduction of wheat
germ agglutinin (WGA) and WGA chimeric constructs has
been mainly used (Braz and Basbaum, 2009; Gradinaru
et al., 2010). Direct synaptic coupling nevertheless needs
to be veriﬁed by complementary approaches (EM or
electrophysiology).IMAGING IN PAIN PATHWAYS
The in vivo challenge
With the optimization of chemical and genetically-
encoded neuronal activity indicators (Looger and
Griesbeck, 2012; Storace et al., 2015), development of
microscopy technologies (Laﬀray et al., 2011;
Sanderson et al., 2014; Winter and Shroﬀ, 2014; Keller
and Ahrens, 2015), and improvement of light delivery
tools (Aravanis et al., 2007; Zhang et al., 2010; Dufour
and De Koninck, 2015), optical recording has become
one of the most popular methods to study the function
of a population of neurons. In particular, the populariza-
tion of two-photon microscopy has disseminated the use
of functional cellular imaging from small neuronal net-
works in vivo (Denk et al., 1990; Zipfel et al., 2003; Kerr
and Denk, 2008). However, compared to its rapidly grow-
ing use in the brain, especially for cortical surfaces, appli-
cations of functional imaging in DRG, spinal cord, and
brainstem are still in their very early stages. Reasons
include movement of DRG, spinal cord and brainstem,
but also the presence of myelin, which is the most scatter-
ing element of light in brain tissue. The spinal cord is
heavily covered with myelinated ascending tracks for
example, signiﬁcantly limiting optical access compared
to cortical structures. Heavy surgical interventions
(laminectomy) are often required to expose DRG, spinal
cord and brainstem for imaging, making the approach
highly invasive. Thus, here we will focus on advances to
enable imaging in skin, dorsal roots, and spinal cord.
Sensory terminals in the skin have not been directly
imaged in vivo; functional imaging in the skin of the ear
in vitro with GCaMP3 was used to study nerve terminals
(Kim et al., 2014). Successful imaging in the skin is critical
to understand the transduction process, including the
interactions between skin cells and nerve ending, which
is an essential component of the generation and modula-
tion of signals in sensory aﬀerents. Imaging of the skin
presents many challenges, however. First, the skin is
highly scattering, so light cannot penetrate very deep
and only superﬁcial layers can be imaged (typically the
ﬁrst 100 lm). Second, in highly vascularized skin, hemo-
globin is a major obstacle; it is one of the highest light
F. Wang et al. / Neuroscience 338 (2016) 248–271 257absorber below 600 nm (Zonios et al., 2001), dramatically
reducing the signal in the ultraviolet and visible ranges.
Third, hairs and the skin itself are highly auto-
ﬂuorescent. Fourth, while studying thermal transduction
may be simpler, combining high precision imaging and
mechanical stimulation is very challenging. Overall, these
obstacles need to be addressed before skin imaging
becomes a routine reality. Hemoglobin absorption can
be solved with red-shifted ﬂuorescent sensors (emitting
>650 nm). A remaining important breakthrough will be
to solve the scattering problem. The advent of physiolog-
ically compatible clearing agents would be particularly
enabling in this respect.
Most studies of primary aﬀerent physiology to date
have focused on recording from single or a few
aﬀerents at a time since they have relied on
electrophysiological techniques. Recording from a wide
population of aﬀerents is becoming critical if one seeks
to understand combinatorial nature of somatosensory
coding akin to that in other sensory systems (Prescott
et al., 2014). The single neuron focus has led to the con-
cept that sensory coding results from activity in single
classes of aﬀerents at a time. Yet, while each class of
aﬀerent may be tuned to a certain stimulus, a stimulus
activates several types of aﬀerents. Thus the problem
must be addressed in terms of population coding, which
calls for the ability to perform population recording
(Prescott et al., 2014). In vivo imaging of dorsal roots is
one strategy to record sensory aﬀerent responses
(Vrontou et al., 2013). The dorsal roots have the advan-
tage that they sit at the surface of the spinal cord, thus
easily accessible for optical imaging. In contrast, imaging
throughout the DRG is more challenging as it is packed
with highly scattering connective tissue. In contrast, cell
bodies are large and allow for more robust (movement-
resistant) monitoring (Davalos et al., 2008). A recent
study reports recording from large numbers of DRG neu-
rons (>1600) at low magniﬁcation with a confocal
approach, but the scan speed remains limited
(0.15 Hz); high-speed functional measurements had to
be performed on zoomed regions (Kim et al., 2016c). A
two-photon microscopy with fast scanning should yield
deeper and faster sampling, enabling monitoring from
large populations at once. Movement remains a continu-
ous challenge with in vivo functional imaging. A few
approaches have been developed to circumvent this chal-
lenge, including a real-time, adaptive movement compen-
sation strategy (Laﬀray et al., 2011). The system requires
a suﬃcient frequency response performance to compen-
sate movements on time scales relevant to Ca2+ tran-
sients (from tens of Hz to kHz). Spinal dorsal horn
imaging has been performed successfully to investigate
the dynamics of glia morphology (Davalos et al., 2008;
Davalos and Akassoglou, 2012) and function of spinal
cord neurons (Johannssen and Helmchen, 2010; Ran
et al., 2016). The presence of highly scattering myelin at
the surface of the spinal cord, in contrast to cortex, signif-
icantly limits depth of imaging for functional two-photon
microscopy.
A major limitation for in vivo cellular imaging studies
has been the need to use anesthesia. The advent ofhead-ﬁxed unanesthetized preparations and
microendoscopy approaches to perform in vivo
functional imaging has been transformative in this
respect (Helmchen et al., 2001; Dombeck et al., 2007;
Dombeck and Tank, 2014; Hamel et al., 2015). A compa-
rable approach for skin, DRG, or spinal cord imaging is
much more challenging however. The development of
spinal windows (Fenrich et al., 2013; Farrar and
Schaﬀer, 2014) or spinal microendoscopy (Belanger
et al., 2012) may yield applications for unanesthetized
conditions. Maintaining stability of proper registration of
the imaging system, be it using a ﬁxed stage or portable
(miniaturized) design, may still remain highly challenging
to withstand abrupt movements and reﬂex responses trig-
gered by noxious stimuli. Many barriers remain, but the
approach nevertheless deserves to be explored to be able
to understand how spinal sensory processing is aﬀected
by motor action. When anesthesia remains necessary,
the choice of anesthetic is critical for compatibility with
Ca2+ imaging. The commonly used ﬂuorothane anesthet-
ics, for example, can interfere signiﬁcantly with Ca2+
responses beyond certain doses.The spatial resolution challenge
Immunostaining or other labeling techniques have been
combined with a confocal and two-photon microscope to
study the distribution and localization of diﬀerent
proteins. For certain types of questions, when resolving
subcellular membrane traﬃcking, molecular interactions
or functional signaling at individual synapses, spatial
resolution become a critical limiting factor for optical
approaches due to the diﬀraction limit. Several
transformative strategies have been developed to
improve on spatial resolution, including STED (Hell and
Wichmann, 1994), PALM (Betzig et al., 2006) and
STORM (Rust et al., 2006) for both ﬁxed tissue and live
cell studies (Godin et al., 2014; Nienhaus and Nienhaus,
2016). And single molecule studies can be used to
resolve structural assemblies and oligomerization
(Jonas et al., 2015, 2016). Single molecule tracking has
revealed particularly instrumental to study receptor diﬀu-
sion on the membrane which emerged as a key mecha-
nism underlying synaptic plasticity (Choquet and Triller,
2013). These super-resolution techniques are challenging
to use in live tissues however, for two reasons. First, the
large amount of time needed to acquire such high-
resolution images is not ideally suited to the sample being
alive and moving. Second, the imaging depth in thick tis-
sue is still limited to less than 100 lm, and the scattering
limits the resolution improvements very rapidly as depth is
increased: for STED, scattering has the eﬀect of diminish-
ing the quality of the null intensity at the center of the
STED beam, and for PALM/STORM, it reduces the
SNR which in turn reduces the resolution improvement.
Structured illumination approaches can also be used,
but are also limited for in vivo applications because they
are based on wideﬁeld strategies and thus heavily
aﬀected by scattering. All of these enhanced resolution
techniques rely on ﬂuorescence however and thus the
addition external labels is required. Other non-
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have been developed (Dehez et al., 2013; Marquet
et al., 2014), but also remain limited for in vivo applica-
tions. Yet, the ultimate goal to understand molecular sig-
naling in normal and pathological conditions, is to
measure quantitatively protein interactions in tissue.
Approaches based on resonance energy transfer have
proven very powerful because they directly reveal protein
interactions within a 10-nm length scale. However they
rely on availability of suitable ﬂuorescent probes, which
are often complex to produce and require the use of
expression systems (Gales et al., 2005). To overcome
these limitations, we developed a spatial domain ﬂuores-
cence ﬂuctuation analysis techniques which oﬀer several
advantages: it can be applied to analysis of images of
both chemically ﬁxed tissue as well as live cells, it is com-
patible with conventional immunolabeling approaches, it
yields robust quantiﬁcation even with highly heteroge-
neous tissue samples and provides quantitative informa-
tion on both protein densities and multimeric
organization. This type of approach thus opens the door
to measuring protein interactions using standard ﬂuores-
cence microscopy in native tissue, including human tis-
sue, which can be key to bridge results in animal and
human studies and capture the molecular underpinnings
of certain pathologies (Godin et al., 2011, 2015).
The temporal resolution challenge
The challenge when imaging circuits is to sample a large
enough number of cells at a suﬃciently high frame rate to
follow their dynamics (Ca2+ or electrical signal). The
simplest approach is to perform rapid scanning of the
imaging laser beam along a fast axis (X) with either
resonant galvo scanners or polygonal mirrors (Veilleux
et al., 2008), while completing the scanning with a slower
scanner along the other axis (Y) (Fig. 2A). Speed of
acquisition can be increased with some degree of paral-
lelization using multifocal of spinning-disk approaches.
Spinning-disk approach limits signal detection however
for two-photon microscopy and a temporal decorrelation
strategy must be implemented for multifocal, multi-
beam, femtosecond pulse approaches (Fittinghoﬀ et al.,
2000) (Fig. 2A). Other non-scanning strategies exist: tem-
poral focusing (Oron et al., 2005), spatial light modulators
(Therrien et al., 2011), HiLo microscopy (Mertz, 2011).
These strategies quickly show their limitations, however:
circuits are rarely limited to a single well-deﬁned 2D plane
and a strategy to scan volumes is necessary (for a review
see Ji et al., 2016). Stage-scanning or rapid focus adjust-
ments in Z are possible, but the sequential acquisition of
stacks of images is often too slow for activity monitoring.
There are two main strategies to increase the imaging
speed: reduce the number of points imaged or parallelize
the detection (Fig. 2B). Strategies that optimize the num-
ber of cells that are imaged using a piezoelectric-mounted
objective and a non-raster scan have been implemented
(Gobel et al., 2007) to provide sparse sampling of a vol-
ume at 10 Hz. An extension of this strategy uses
acousto-optic deﬂectors (AOD) to deﬂect the beam in
3D and sample an arbitrary sequence of points at
>100 kHz (Salome´ et al., 2006; Akemann et al., 2015)(Fig. 2B). However, these two methods do not obtain
images per se, and any movement in the sample will
aﬀect the resulting data. Methods that parallelize the
detection can achieve higher imaging rates without sacri-
ﬁcing points. A promising approach for in vivo applications
is SCAPE microscopy (Swept confocally-aligned planar
excitation), which is essentially a light-sheet in a single
objective, that permits volume imaging of neuronal circuits
at video rates thanks to an oblique line scanning strategy
coupled with a camera (Bouchard et al., 2015) (Fig. 2C).
Another strategy that is compatible with laser-scanning
microscopes is to use Bessel beams and line focusing
instead of standard point focusing to obtain a complete
projection of a stack in a single image eliminating the
need for z scanning (Dufour et al., 2006). When labeled
cells are sparsely distributed, a single 2D projection of a
volume can be suﬃcient to sample from all cells
(Fig. 2C). Alternatively, stereographic images can be
obtained if two images at diﬀerent angles are taken
(Theriault et al., 2013).
The depth challenge
The micron-sized wavelength of light in optical imaging
gives it its great spatial resolution but also consequently
makes it sensitive to scattering from micron- and
submicron-sized index of refraction inhomogeneities.
This scattering is responsible for the low penetration
depth of optical imaging. Multiphoton microscopy has
supplanted confocal microscopy for most applications in
thick tissue imaging since it suﬀers from scattering only
for illumination and much less so for detection. Indeed,
once the multiphoton illumination has generated a
source of light at the focal spot, tissue scattering plays a
mostly beneﬁcial role in partially redirecting some of that
light into the objective that would have otherwise been
lost into the tissue. It is this mechanism that makes
possible other contrasts based on coherent processes
such as second harmonic generation (SHG)
(Campagnola and Loew, 2003), third harmonic generation
(THG) (Debarre et al., 2006; Farrar et al., 2011) and
coherent anti-Stokes Raman scattering (CARS) (Evans
et al., 2005). To maximize collection for any multiphoton
process, objectives with a large NA are therefore impor-
tant, but even more important is a large ﬁeld of view to col-
lect all of the diﬀuse, scattered light. Such objectives are
now available from most major companies following
design considerations outlined previously (Oheim et al.,
2001).
Still, poor excitation eﬃciency due to reduced peak
intensity (loss of ballistic photons) by scattering remains
the limiting factor for shallow imaging depth. This peak
intensity reduction after scattering can be recovered in
two ways. First, one can use high-peak intensity
ampliﬁed pulses containing a larger number of photons
at the expense of a lower repetition rate (Oheim et al.,
2001). This will increase the signal with the reduction of
the repetition rate. This low repetition rate however
becomes an issue if it is signiﬁcantly lower than the pixel
clock rate. Increasing the peak intensity also brings
another problem, whereby ﬂuorescence from outside of
the focal area starts adding background noise to the sig-
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Fig. 2. Diﬀerent microscopy strategies for rapid imaging from small neural networks. (A) The simplest approach is to perform rapid scanning of the
imaging laser beam (left). Increase in speed can be achieved by parallelizing the beam with either multiple lenses (middle) (Fittinghoﬀ et al., 2000) or
a spinning disk strategy (right). (B) Another strategy to increase imaging speed is to reduce the number of sampling points or simplify the beam
trajectory: One can use acousto-optic deﬂectors (AOD) to deﬂect the beam very rapidly between a small sequence of chosen points (left) (Salome´
et al., 2006) or use spatial light modulators to distribute the laser illumination to speciﬁc areas of the ﬁeld (middle) (Therrien et al., 2011). Finally,
using a conventional galvo mirror approach, one can program the laser trajectory to intersect the points of interest within the network of cells studied
(right) (Gobel et al., 2007). These methods do not obtain images per se, and any movement in the sample will aﬀect the resulting data. (C) Methods
that minimize scanning also include light-sheet and Bessel beam microscopy. An interesting avenue for application of light-sheet microscopy to
in vivo conditions is SCAPE (right), which uses an oblique illumination light-sheet allowing for the use of a single objective for both excitation and
collection (Bouchard et al., 2015). Using Bessel beams (line focusing; left) instead of standard point focusing yields a complete projection of a stack
into a single image, eliminating the need for z scanning (Dufour et al., 2006; Theriault et al., 2013).
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this background ﬂuorescence, three-photon excitation
has been proposed since the optical sectioning from this
process is more pronounced than for two-photon excita-
tion. This was recently demonstrated to lead to an impres-
sive 1-mm imaging depth in the cortex for selected
ﬂuorophores (Horton et al., 2013). The second strategy
to recover a large peak intensity is to use adaptive optics
to pre-compensate tissue scattering. This has been doneby many groups to increase imaging depth while main-
taining spatial resolution, but challenges remain to extract
the most of what this technique could theoretically provide
(Ji et al., 2010).
To simply bypass scattering altogether, micro-
endoscopes (or GRIN relay lenses) can be used to
bring the light directly to the area of interest either in
table-top (Kim et al., 2010; Belanger et al., 2012) or por-
table microscopes (e.g., systems commercialized by
260 F. Wang et al. / Neuroscience 338 (2016) 248–271Inscopix and Doric Lenses). This has been demonstrated
with many multiphoton modalities to image Ca2+ activity
in the cerebellum (Barretto et al., 2009). However,
because GRIN relay lenses must maintain a reasonable
ﬁeld of view, their large diameters (between 300 lm and
1000 lm) tend to be problematic if one needs to go deep
in the brainstem or spinal cord of rodents, and are there-
fore limited to the brain after careful surgery.CONTROLLING PAIN PATHWAYS
Beyond recording, precise activity control of
subpopulations of neurons is also critical to establishing
how sensory input is encoded and contribute to pain or
pain modulation. To this end optogenetics strategies
applications for pain research are only beginning to
emerge. One reason is that several components of pain
pathways (DRG, spinal cord, and brainstem) have
remained diﬃcult to access, mainly because they are
encased within the vertebral column. Even skin, which is
highly scattering (see above) has been a signiﬁcant
obstacle at ﬁrst.Contactless, activation of pain pathways
One initial breakthrough has been the design of a mouse
line where Nav1.8 aﬀerents (expressing ChR2) could be
activated by light shining across the skin (Daou et al.,
2013). The advantages of this tool are manifold. First, it
allows selective activation of nociceptors, which has not
been possible even with electrical stimulation. Second,
activation is achieved without touching the skin, which
avoid other tactile stimulation, allowing isolation of that
input. Third, it allowed performing controlled activation
of the same aﬀerent populations across preparations:A
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Fig. 3. Diﬀerent conﬁgurations of ﬁber implants for controlled stimulation of di
still tethered to the light source; this has the advantage that higher pow
measurements of light transmission across the highly scattering dorsal surfa
have the advantage that they can be implanted in diﬀerent parts of the body,
cranially. Modiﬁed from Montgomery et al. (2015).from spinal cord explants to intact animals. Complemen-
tary approaches were developed to produce selective
inhibition of sensory aﬀerent endings in the skin (Iyer
et al., 2014; Daou et al., 2016). These strategies have
the disadvantage that maintaining well-controlled stimuli
is diﬃcult as the animal is moving, especially when
attempting to stimulate nociceptors. Thus to produce sen-
sitization with repetitive stimulation of nociceptors, ani-
mals had to be brieﬂy anesthetized (Bonin and De
Koninck, 2014). One way to overcome this limitation is
to introduce the light source into the body. This was
achieved using wireless microLED implanted in diﬀerent
regions (e.g., subcutaneously, at the spinal cord surface,
or the brain (Montgomery et al., 2015, 2016) (Fig. 3B).
One drawback of this approach is that the power that
can be deployed to date is insuﬃcient for eﬀective activa-
tion of inhibitory opsins (ArchT, NpHR). Improvements in
opsins will likely help overcome such limitation. Recently,
use of the step-function inhibitory opsin SwiChR has been
shown to produce eﬀective analgesia for up to 60 s with
just one brief pulse of blue light delivered transdermally
(Iyer et al., 2016). An alternative strategy to microLED
implants has been to use an epidural ﬁber, which can
be connected to an external source; it provided suﬃcient
power to produce analgesia in mice where ArchT was
expressed in aﬀerent nociceptors (Bonin et al., 2016)
(Fig. 3A). The advantage of the latter design is that it
can also be engineered for concurrent photometric mea-
surements (see below). Wireless approaches often have
the current drawback that they require the use of resonant
cavity for energy transfer and movement of the animal
can aﬀect the orientation of the receiving coil, which can
aﬀect the eﬃciency of energy transfer. Moreover, the res-
onant cavity limits ﬂexibility for certain behaviors. An alter-
native wireless system that harvests its energy from radioB
ﬀerent parts of pain pathways. (A) Epidural ﬁber implant. The animal is
ers can be used than with microLEDs. The lower panels illustrate
ce of the spinal cord. Modiﬁed from Bonin et al. (2016). (B) microLED
here subcutaneous and adjacent to the triceps surae muscles or sub-
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Fig. 4. The growing palette of designs of ﬁber-optics and multimodal probes. (A) Fiber-optics can be micro-engineered to focus light, send it
sideways or diﬀuse it at their tip. (B) Micro-optrode based on a specialty ﬁber with an optical core and a hollow core and metal coating for multimodal
measurements. The hollow core can be ﬁlled with an electrolyte for single-cell electrophysiological recording, while the metal coating can serve for
ﬁeld recording. The traces on the right illustrate correlated optical signals (from an intracellular Ca2+ sensor) and electrical signals (extracellularly
recorded action potentials). Modiﬁed from Dufour et al. (2013). (C) Schematic representation of diﬀerent types of combined electrical and optical
probe conﬁguration, their illumination ﬁeld (blue or red) as well as their electrical recording ﬁeld (brown concentric circles). Drug delivery capability is
represented by yellow drops. Drawings are to relative scales to illustrate the diﬀerent bulkiness of each approach as well as the spatial relationships
between the optical and electrical ﬁelds and cell populations being probed. From Dufour and De Koninck (2015). (D) Block diagram of a wireless
headstage system. The headstage transmits the neural data wirelessly to a base station which is connected to a computer host. Note the presence
of an onboard processor for adaptive detection of spikes, and wavelet compression of the data before transmission to minimize bandwidth usage.
From Gagnon-Turcotte et al. (2016).
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262 F. Wang et al. / Neuroscience 338 (2016) 248–271frequency (RF) transmitter has recently been developed,
which eliminates the need for resonant cavity (Park
et al., 2015).Guiding light
Fiber-optics technology has been at the core of
development for optogenetics. They have represented
the tool of choice to reach deep brain structures, but
also hard-to-reach areas (Dufour and De Koninck, 2015;
Bonin et al., 2016). The physical parameters of the ﬁber
(core size, numerical aperture) are important parameters
to determine the illumination volume achieved to match
the needs of the experiment (for detailed review of practi-
cal considerations guiding the choice of ﬁber probe and
parameters to use, see Dufour and De Koninck, 2015).
Microengineering ﬁber tip and combination with micro-
optical components open a wide array of possibilities in
using ﬁber optics technologies (Fig. 4A), including focus-
ing, side illumination, diﬀusion, etc. Fiber optics can also
be tapered (e.g., pulled like conventional glass micropip-
ettes used for electrophysiological recording) down into
very small tips that can be particularly instrumental for
measurements from few cells, or even single cells
(LeChasseur et al., 2011; Dufour et al., 2013) (Fig. 4B).
Choosing (or engineering) ﬁbers of the right core size with
the right tip size is important because larger size ﬁbers
must be positioned further away from the target nucleus
to stimulate. The farther the ﬁber tip, the weaker the signal
at the target site due to scattering. In excitation mode, one
can always increase the intensity of the source, but care
must be taken not to reach toxic or damaging intensities
(Dufour and De Koninck, 2015). Another important key
feature of ﬁber probes is that they can be used not only
for delivering light to a target tissue but also to collect
emitted light. Even single-core ﬁbers, while they cannot
serve easily for imaging, can be very instrumental for col-
lecting information, especially considering the growing
array of sensors available and their very speciﬁc target-
ing. Hence, akin to speciﬁcity achieved by optogenetic
stimulation, regardless of the spatial conﬁnement of the
light, speciﬁcity in collected signals from the tissue can
be achieved using a non-imaging single-core ﬁber. By
integrating information emanating from a volume of cells,
spatial information is not necessary as long as the signal
originates from speciﬁc subpopulations of cells or even
speciﬁc subcellular compartments (e.g., nucleus, endo-
plasmic reticulum, mitochondria). This type of ﬁber-
based photometry has the advantage that it can rely on
optical probes that are much less invasive than micro-
endoscopes for example (Kim et al., 2016a). Multimode
ﬁbers are compatible with multicolor acquisition to the
same extent that imaging devices are (Dufour et al.,
2013). At the single-cell level, combined optical and elec-
trical recording can be particularly powerful to syn-
chronously probe intracellular signaling events and ﬁring
activity of the cells (Fig. 4B).Multimodality
An important asset of optical modalities and optical
devices is that they can easily be combined with othermodalities, such as electrophysiological recording.
There is no good reason to set aside the ability to
record electrophysiologically the activity of neurons,
even in the advent of voltage-sensitive dyes. Indeed,
unlike ﬂuorescence measurements, electrophysiological
recordings come at virtually no cost; no dye introduction
or transfection is needed. Extracellular recording is non-
invasive to the cell, minimally fades with time (unlike
photobleaching of ﬂuorescent dyes) and is non-toxic (no
photochemistry involved). Mixed optical and
electrographic probes have thus been designed and
termed optrodes or optodes and clever design can allow
co-registered optical and electrical recording from single
cells (LeChasseur et al., 2011) or even a combination of
single-cell and ﬁeld recording (Dufour et al., 2013)
(Fig. 4B). Combined optical and electrical probes come
in many ﬂavors, including electrode arrays. For a detailed
review of design strategies see (Dufour and De Koninck,
2015). The choice of the electrical recording element is
an important factor when choosing electrode as the illumi-
nation of certain metal electrodes can produce undesired
photoelectric artifacts (Zhang et al., 2010). In arrays, the
spatial relationship between the optical probes and the
electrode probes varies and, while 1:1 spatial co-
registration would ultimately be ideal, it is not necessarily
needed if the optical probes are only desired to produce
broad stimulation. Other modalities can also be combined
and considerable eﬀorts are deployed to produce minia-
turized probes and new materials for combined optical,
electrical and chemical delivery and sensing. No single
design oﬀers a universal solution, but the combination of
optical and electrical elements of diﬀerent sizes and
geometries can be permutated to allow for a large spec-
trum of optrode designs addressing diﬀerent needs (see
Fig. 4C). The need to take full advantage of optogenetic
and multimodal monitoring in freely behaving animals
has driven the design of wireless device (see above and
Fig. 4D). While not always necessary, they can become
quite useful when studying complex behavior requiring
the animal to move freely in conﬁned areas (e.g., small
tunnels) or engaged in social interactions. An important
challenge is the combination of multiple signals (e.g.,
electrical and optical), which is not trivial (Gagnon-
Turcotte et al., 2015) (Fig. 4D). To manage a high channel
count and the high sampling rates necessary for electrical
recordings with suﬃcient information about spike shape,
strategies must be developed to introduce maximum on-
chip processing capabilities and data compression algo-
rithms before the signals are transferred wirelessly
(Gagnon-Turcotte et al., 2016) (Fig. 4D).
Scaling to humans; size matters
A ﬁnal, often overlooked, consideration regarding
translation of optogenetics to higher species, and in
particular to human applications, is that the increase in
size of brain structures presents a major challenge.
Indeed while distance for single scattering events
remains the same as the tissue grows, the distance
between elements of interest increases. The result is a
dramatic decrease in eﬃcient light transport from the
source to the target areas in tissue. Making things
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scattering in brain tissue) disproportionately grows in
primates and humans (two- to threefold). Thus, even if
the prospect of using viral vector-mediated somatic
gene transfer for clinical applications in humans is not
necessarily so distant (Kaufmann et al., 2013), eﬀective
light delivery in human tissue is an obstacle that will have
to be tackled with the design of miniaturized distributed
delivery systems.
The challenge of gene therapy
The eﬃciency of any gene therapy ﬁrst relies on vector
delivery and expression in the appropriate cell type and
so far, this has been extremely diﬃcult to achieve. For
pain therapeutics, while several strategies appear
promising at the pre-clinical level, very few advance to
the next phases (Guedon et al., 2015). Herpes Simplex
Virus-1 (HSV-1) based vectors, which have a natural ten-
dency to target sensory neurons have been used in sev-
eral models of pain and AAVs, which have a broader
spectrum of targets have also shown some promising
results (Beutler and Reinhardt, 2009). Adenoviral and len-
tiviral vectors have also been used but none appear to
possess all the required qualities for a perfect gene trans-
fer vehicle in humans. Major barriers to viral vector-based
gene therapy include induction of an immune response,
the presence of neutralizing antibodies, delivery/transport
to the target cells, and clearance of the vector through the
liver. Much work remains to overcome these barriers. To
date, most eﬀorts have been directed to improvement of
speciﬁc characteristics of existing vectors through rational
design and directed evolution (Kotterman and Schaﬀer,
2014). Variant designs and capsid modiﬁcation are
promising avenues and this ﬁeld evolves rapidly. Other
barriers to this fast advancing ﬁeld are the constraints of
high regulation scrutiny. As observed with research grade
viral vectors, production conditions of these tools are crit-
ical as diﬀerent results can be obtained with seemingly
identical general vector design. If this therapeutic avenue
is to spread, requirements for large quantities, uniformly
produced, high titer and better-characterized products
are expected to become available (van der Loo and
Wright, 2016).
PROBING WITHOUT LABELS
Many naturally-occurring molecules are ﬂuorescent, with
some of them having a brightness that is even
comparable to some of the engineered proteins (Zipfel
et al., 2003). These endogenous signals, although usually
discovered serendipitously, oﬀer molecular speciﬁcity, are
naturally perfectly safe, and do not suﬀer from the many
diﬃculties associated with exogenous labeling (protocols,
inhomogeneities, etc. . .). For these reasons, label-free
approaches have been developed and have had success
for a number of targets such as FAD, NADH, serotonin,
lipids and myelin, and collagen. It has been shown for
instance, that FAD/NADH can be used to assess the
metabolism of cells, that two-photon ﬂuorescence at
600-nm excitation can be used to image serotonin, and
that activity modulates slightly the ﬂuorescence of ﬂavo-protein when excited around 400 nm (Maiti et al., 1997;
Jongen et al., 2014). Despite the signiﬁcant advantage
of label-free strategies, their use is often limited by the
overall instability of the ﬂuorescence (photobleaching or
photoswitching). In addition, they usually are not targeting
the optimal molecule for a particular readout (e.g., ﬂavo-
protein for activity).
A technique that has seen good adoption is vibrational
microscopy, which relies on molecular vibrations for
speciﬁcity. Termed under the name ‘‘Coherent Raman”
techniques, CARS and Stimulated Raman Scattering
(SRS) microscopies make use of two laser pulses at
diﬀerent frequencies where the diﬀerence is equal to
vibration frequency of a molecule. For CARS, the
molecule will re-emit a photon at a diﬀerent and shorter
wavelength in a process that makes it behave in
practice like multiphoton-excited ﬂuorescence. This
makes the CARS modality compatible with laser-
scanning ﬂuorescence microscopy. SRS on the other
hand, relies on the modulation of one beam to impart a
very small modulation on the other beam that is
proportional to the number of vibrating molecules. This
makes SRS ideal for spectroscopy applications since
the signal is linear with the concentration as opposed to
CARS where it is quadratic. It however requires
modiﬁcations to the microscope that are non-standard
for ﬂuorescence microscopes. Certain vibrations such
as the stretch vibration of CH2 in the high wavenumber
region can be used to image myelin, since the lipids that
make up the membranes are rich in CH2. This has then
been used to quantify neurodegeneration in nerve crush
injuries, a common model of nerve injury-induced
neuropathic pain. This is illustrated in Fig. 5A, where a
panorama of the myelin across the nerve is performed
with CARS microscopy, one week after injury. In this
example, the mapping spans several millimeters of
nerve on both sides of the injury site, across healthy
regions, with intact myelinated axons, to areas with
Wallerian degeneration distal to the lesion with respect
to the cell bodies of the sensory neurons. Thus an
optical microscopy approach like CARS allows for rapid
spanning of large areas of tissue, while preserving
submicron scale resolution. Fig. 5B depicts the well
aligned and globally oriented myelin sheaths of live
white matter in rat spinal cord tissue. Using
reconstructed transverse image from z-stack –a contact-
free CARS optical slice– (Fig. 5C), morphometric
analysis such as myelin thickness measurements can
be conducted over time (Fig. 5D–F) (Belanger et al.,
2009, 2012; Begin et al., 2013, 2014). With additional data
taken at diﬀerent time points, demyelination at 2-weeks
post-injury followed by remyelination at 4-weeks could
be measured with cellular resolution (Henry et al., 2009;
Belanger et al., 2011) indicating that such an approach
can be used for quantitative longitudinal studies in vivo
(Fig. 5F). A recent advance in CARS microscopy is the
use of polarization, increasing sensitivity down to molecu-
lar organization. Polarization CARS (P-CARS) uses exci-
tation beams with diﬀerent states of polarization and takes
advantage of the high level of symmetry of certain struc-
tures like the myelin sheaths (Fig. 5G). Indeed, CH2 mole-
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Fig. 5. Label-free imaging and live morphometry of myelinated axons with CARS. (A) Large-scale and high-resolution CARS map of a crushed
sciatic nerve, at 1-week post-injury, at the millimeter scale yet preserving the submicron resolution. Scale bar = 250 lm, modiﬁed from Belanger
et al. (2011). Note the typical Wallerian degeneration in the section distal to the injury with respect to the cell bodies of the sensory aﬀerents. It is
mostly ﬁlled with myelin debris with no distinguishable sign of myelinated axons. In the region proximal to the crush site with respect to the cell
bodies, myelin swelling and spheroids appear. In the healthy region, intact myelinated axons are observed. (B) CARS image of rat spinal cord
tissue. Scale bar = 30 lm. (C) Reconstructed transverse image from z-stack allowing morphometry measurements. Same scale as (B). (D)
Histogram of caliber classes revealing that the mean axon diameter is close to 7 lm for the probed population. (E) Scatter diagram of the g-ratio
versus the axon caliber showing a variation between 0.5 and 0.65. The g-ratio is calculated by dividing the axon by the ﬁber diameter. Graph in (B–
E) are modiﬁed from Belanger et al. (2009). (F) Myelin thickness (circles, red) and the g-ratio (squares, black) versus time after nerve injury.
Measurements can be performed across time in vivo. Note the myelin thickness decreases at 2-weeks post-injury, revealing signiﬁcant
demyelination. At 4-weeks, myelin thickness augments, showing partial yet incomplete remyelination. Modiﬁed from Belanger et al. (2011). (G)
Polarization dependence plot, the black curve is from the focal myelin discontinuity and the red one from the normal region. (H) CARS image of a
Mauthner axon in a zebraﬁsh. Scale bar = 3 lm. (I) P-CARS image of the same axon revealing discontinuity on the left side. Black rectangles
indicate where the polarization dependence plot in (G) was taken. Same scale bar as (H), (H–I) are modiﬁed from Turcotte et al. (2016).
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limited excitation volume. Their molecular dipoles are par-
tially aligned and this distribution can be characterized by
a main orientation (Belanger et al., 2015). Using this prin-
ciple, P-CARS was recently used to assess the myelin
molecular order during promyelination chemical treat-
ments in zebraﬁsh. The approach revealed myelin discon-
tinuities that were invisible with regular CARS (Fig. 5H-I).Subtle alterations to the nanoscopic spatial organization
of the several concentric lipid lamellae forming myelin
sheaths thus became detectable optically by P-CARS
(Turcotte et al., 2016). Hence CARS imaging provides
quantiﬁable endogenous signal, which can be used to
assess myelin health and has the potential to become a
powerful tool in the quest to understand nerve degenera-
tion and repair.
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The array of tools becoming available to measure and
manipulate cellular and molecular events in intact tissue
is growing at an accelerated pace. The level of spatial
and temporal precision achievable is unprecedented, but
it is the ability to interrogate cell function in behaving
animals that is making the convergence of technologies
particularly transformative for the ﬁeld of pain. This is
because the pain system involves so many interacting
components. Thus, on the one hand, it is diﬃcult to
ascertain the contribution and net functional impact of
speciﬁc cellular mechanisms at the behavioral level
without measuring and manipulating both in the same
setting. On the other hand, this or that mechanism is
likely to be engaged, or heavily modulated, by a
multitude of factors, including the behavioral context in
which the subject is placed. Multimodal, minimally
invasive technologies are essential to untangle the
complex interplay that exist between cell signaling and
behavior. Yet, in the context of the drug discovery and
validation process, the enormous adaptability of the
CNS represents an equally important challenge,
because the diseased brain can easily adjust to drug
treatment, eﬀectively counteracting its eﬀectiveness
(Ratte and Prescott, 2016). The ability to measure molec-
ular processes over time in a non-invasive fashion
becomes critical to understand the response of the CNS
to drug treatment. The emerging and converging light-
based technologies oﬀer unprecedented opportunities to
ﬁll this important gap in a translational research endeavor.
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